INTRODUCTION
Diabetic nephropathy is one of the three major microangiopathies of diabetes mellitus, which is often related to mortality in diabetic patients.
Genetic predisposition has been implicated in its development [1] [2] . The C677T (Ala->Val) variant of the methylenetetrahydrofolate reductase (MTHFR) gene has been reported to result in reduced enzyme activity and impaired homocysteine/folate metabolism, leading to moderate hyper-homocysteinaemia [3] [4] [5] , which has been demonstrated to an important cardiovascular risk factor [3] . And the C677T mutation of the MTHFR gene has been reported to be associated with increased susceptibility for the development of coronary heart disease [5] . A recent study also suggests that this mutation is associated with another major diabetic microangiopathy of retinopathy [6] , which indicates a possible importance of this genetic variant in development of diabetic microangiopathies as well as vascular diseases. Recently, it was reported that this variant is associated with diabetic nephropathy [7] . A previous report also suggests an importance of hyperhomocysteinaemia in the development of diabetic nephropathy [8] . These observations suggest that the C677T mutation may be associated with diabetic nephropathy. and those without nephropathy. The PCR products were digested with Hinf I separated on 8% poly-acrylamide gel. RESULTS AND DISCUSSION The frequencies of C/C (Ala/Ala), C/T (Ala/Val) and T/T (Val/Val) genotypes were not different between the two groups ( x 2 =1.74, p=0.42). The proportion of the T/T genotype carriers was not increased in patients with diabetic nephropathy ( % 2 =0.037, p=0.85). The T allele frequency was not different between the two groups (Fisher's exact test, p=0.34). The genotype frequencies were not different by comparing patients with macro-(Urine >300 n g/day) or microalbuminuria (>30 n g/day) with those without nephropathy (<30 y g/day). Although the C->T mutation has been reported to be associated with diabetic retinopathy and nephropathy in the previous reports [6] [7] , its association was absent with diabetic nephropathy in the analysed population. As the role of homocysteine metabolism in the pathogenesis of diabetic microangiopathies is largely unknown, it is currently not possible to have appropriate explanations for its association with diabetic nephropathy in the previous study. In conclusion, although previous observations suggest a role of the C677T mutation of the MTHFR gene in the development of diabetic nephropathy, it seems to be premature to conclude that this mutation is associated with diabetic nephropathy in Japanese.
